on Quantum Biopharma Ltd.
Quantum Biopharma Ltd. to Dual List on Upstream Market
Quantum BioPharma Ltd., a biopharmaceutical company, announced its shares will be dual listed on Upstream, a MERJ Exchange market and securities trading app. Trading will commence on January 14, 2025, under the symbol 'QNTM'. This strategic move aims to expand Quantum's investor base globally, providing liquidity and enhancing price discovery.
International investors can trade using various payment methods, including credit cards, PayPal, and cryptocurrencies. The Upstream platform offers real-time trading with a transparent order book designed to prevent market manipulations.
Quantum's CEO, Zeeshan Saeed, stated, "Dual listing supports our goal of building shareholder value as we develop treatments for neurodegenerative and metabolic disorders." Full trading instructions are available on Quantum's website.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Quantum Biopharma Ltd. news